This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1977:28:489-515.

doi: 10.1146/annurev.me.28.020177.002421.

BCG as adjuvant immunotherapy for neoplasia

E M Hersh, J U Gutterman, G M Mavligit

PMID: 324372
DOI: 10.1146/annurev.me.28.020177.002421

Review

BCG as adjuvant immunotherapy for neoplasia

E M Hersh et al. Annu Rev Med. 1977.

. 1977:28:489-515.

doi: 10.1146/annurev.me.28.020177.002421.

Authors

E M Hersh, J U Gutterman, G M Mavligit

PMID: 324372
DOI: 10.1146/annurev.me.28.020177.002421

No abstract available

PubMed Disclaimer

Similar articles

BCG in tumor immunotherapy.
Baldwin RW, Pimm MV. Baldwin RW, et al. Adv Cancer Res. 1978;28:91-147. doi: 10.1016/s0065-230x(08)60647-8. Adv Cancer Res. 1978. PMID: 360797 Review. No abstract available.
Immunotherapy from malignant disease.
Goodnight JE Jr, Morton DL. Goodnight JE Jr, et al. Annu Rev Med. 1978;29:231-83. doi: 10.1146/annurev.me.29.020178.001311. Annu Rev Med. 1978. PMID: 348035 Review. No abstract available.
Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G. Mathé G. Recent Results Cancer Res. 1976;55:1-402. Recent Results Cancer Res. 1976. PMID: 1087040 No abstract available.
Immunotherapy of cancer: current status.
Goodnight JE, Morton DL. Goodnight JE, et al. Prog Exp Tumor Res. 1980;25:61-88. doi: 10.1159/000403177. Prog Exp Tumor Res. 1980. PMID: 6986637 Review. No abstract available.
Immunotherapy for malignant disease.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1976 Sep 24;18(20):83-4. Med Lett Drugs Ther. 1976. PMID: 1066519 No abstract available.

See all similar articles

Cited by

Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8.
Block LH, Georgopoulos A, Mayer P, Drews J. Block LH, et al. J Exp Med. 1978 Nov 1;148(5):1228-40. doi: 10.1084/jem.148.5.1228. J Exp Med. 1978. PMID: 363971 Free PMC article.
Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity.
Kalafati L, Kourtzelis I, Schulte-Schrepping J, Li X, Hatzioannou A, Grinenko T, Hagag E, Sinha A, Has C, Dietz S, de Jesus Domingues AM, Nati M, Sormendi S, Neuwirth A, Chatzigeorgiou A, Ziogas A, Lesche M, Dahl A, Henry I, Subramanian P, Wielockx B, Murray P, Mirtschink P, Chung KJ, Schultze JL, Netea MG, Hajishengallis G, Verginis P, Mitroulis I, Chavakis T. Kalafati L, et al. Cell. 2020 Oct 29;183(3):771-785.e12. doi: 10.1016/j.cell.2020.09.058. Cell. 2020. PMID: 33125892 Free PMC article.
'Trained immunity': consequences for lymphoid malignancies.
Stevens WB, Netea MG, Kater AP, van der Velden WJ. Stevens WB, et al. Haematologica. 2016 Dec;101(12):1460-1468. doi: 10.3324/haematol.2016.149252. Epub 2016 Nov 10. Haematologica. 2016. PMID: 27903713 Free PMC article. Review.
In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions.
Maes H, Cocito C. Maes H, et al. J Cancer Res Clin Oncol. 1996;122(12):727-34. doi: 10.1007/BF01209120. J Cancer Res Clin Oncol. 1996. PMID: 8954170 Free PMC article.
Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions.
Wang G, Wang Y, Ma F. Wang G, et al. Cell Biosci. 2024 Feb 17;14(1):24. doi: 10.1186/s13578-024-01207-7. Cell Biosci. 2024. PMID: 38368397 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc